Aborted and refractory status epilepticus in children: a comparative analysis

Florise A C P Lambrechtsen1, Jeffrey R Buchhalter

  • 1University Medical Center Groningen, Groningen, The Netherlands.

Epilepsia
|December 21, 2007
PubMed

Insights

Refractory status epilepticus (RSE) in children is linked to higher mortality and worse long-term outcomes compared to medically aborted status epilepticus (ASE). Predictors of poor outcome include prolonged seizures, acute etiology, nonconvulsive SE, and young age.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Neuroscience

Background:

  • Status epilepticus (SE) is a neurological emergency in children.
  • Differentiating between medically aborted SE (ASE) and refractory SE (RSE) is crucial for prognosis.
  • Understanding predictors of long-term outcomes in pediatric SE is essential for management.

Purpose of the Study:

  • To compare demographics, clinical features, etiology, and EEG findings between ASE and RSE in children.
  • To describe treatment responses in pediatric SE.
  • To identify predictors of long-term outcomes in children experiencing SE.

Main Methods:

  • Retrospective review of medical records and EEG logs for children (under 18) with SE.
  • Inclusion criteria: hospitalization between 1994-2004 at Mayo Clinic, Rochester.
  • Analysis of patient data including demographics, clinical characteristics, etiology, EEG findings, treatment, and outcomes.

Main Results:

  • 154 children had SE; 61% ASE, 39% RSE.
  • RSE associated with family history of seizures, higher seizure frequency, more AEDs, nonconvulsive SE, and focal/electrographic seizures on EEG.
  • In-hospital mortality higher in RSE (13.3%) vs. ASE (2.1%). RSE survivors had more neurological deficits and epilepsy.
  • Poor outcome predictors: prolonged seizure duration, acute symptomatic etiology, nonconvulsive SE, and age < 5 years.

Conclusions:

  • Specific patient and clinical factors predict RSE development and poor outcomes in children.
  • Aggressive treatment approaches may improve treatment response and outcomes.
  • Further prospective, randomized trials are needed to optimize SE treatment protocols in children.
Abstract

Related Concept Videos

Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...